Cellosaurus logo
expasy logo

Cellosaurus BT320 (CVCL_WW58)

[Text version]
Cell line name BT320
Synonyms BT 320; CPDM_1295X
Accession CVCL_WW58
Resource Identification Initiative To cite this cell line use: BT320 (RRID:CVCL_WW58)
Comments Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
Characteristics: Low-passage-number culture.
Characteristics: Can grow as a neurosphere (PubMed=34610309).
Omics: Genomics; Whole exome sequencing.
Omics: Transcriptomics; RNAseq.
Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
Sequence variations
Disease Glioblastoma, IDH-wildtype (NCIt: C39750)
Glioblastoma (ORDO: Orphanet_360)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 74Y
Category Cancer cell line
Web pages Provider; CPDM; CPDM_1295X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
Publications

PubMed=27723727; DOI=10.1038/nbt.3697; PMCID=PMC5142231
Stevens M.M., Maire C.L., Chou N., Murakami M.A., Knoff D.S., Kikuchi Y., Kimmerling R.J., Liu H.-Y., Haidar S., Calistri N.L., Cermak N., Olcum S., Cordero N.A., Idbaih A., Wen P.Y.-C., Weinstock D.M., Ligon K.L., Manalis S.R.
Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate.
Nat. Biotechnol. 34:1161-1167(2016)

PubMed=34610309; DOI=10.1016/j.celrep.2021.109788
Stockslager M.A., Malinowski S., Touat M., Yoon J.C., Geduldig J., Mirza M., Kim A.S., Wen P.Y.-C., Chow K.-H., Ligon K.L., Manalis S.R.
Functional drug susceptibility testing using single-cell mass predicts treatment outcome in patient-derived cancer neurosphere models.
Cell Rep. 37:109788.1-109788.12(2021)

Cross-references
Chemistry resources PharmacoDB; BT320_134_2019
Encyclopedic resources Wikidata; Q93432623
Entry history
Entry creation06-Sep-2019
Last entry update10-Apr-2025
Version number9